Question from Deputy Ken O'Flynn - PQ 15812-26
Deputy O'Flynn asked about the health technology assessments conducted in respect of tirzepatide. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked about the health technology assessments conducted in respect of tirzepatide. Read the HSE response.
Deputy O'Flynn asked about safeguarding and clinical governance standards that currently apply to gender identity services for minors. Read the HSE response.
Deputy O'Rourke asked about the support for Clann Mór in Meath. Read the HSE response.
Deputy O'Flynn asked about the full health technology assessment of tirzepatide for type 2 diabetes. Read the HSE response.
Deputy Cullinane asked about the number of incidents reported against service users by level of reported harm. Read the HSE response.
Deputy O'Flynn asked about reviews relating specifically to gender identity services for minors since 1 January 2020. Read the HSE response.
Deputy O'Flynn asked about the the formal methodology used when evaluating international clinical guidance. Read the HSE response.
Deputy Cahill asked how many new jobs will be created in the new Killarney Community Hospital. Read the HSE response.
Deputy Cullinane asked about the number of capital projects submitted to the HSE estates for Waterford. Read the HSE response.
Deputy Brady asked about a national brain injury case management service. Read the HSE response.